These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37141111)

  • 1. Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?
    Wouthuyzen-Bakker M; Scheper H
    Expert Rev Anti Infect Ther; 2023; 21(7):695-701. PubMed ID: 37141111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
    BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention.
    Ottesen CS; Troelsen A; Sandholdt H; Jacobsen S; Husted H; Gromov K
    J Arthroplasty; 2019 Feb; 34(2):365-368. PubMed ID: 30401558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.
    Lora-Tamayo J; Senneville É; Ribera A; Bernard L; Dupon M; Zeller V; Li HK; Arvieux C; Clauss M; Uçkay I; Vigante D; Ferry T; Iribarren JA; Peel TN; Sendi P; Miksic NG; Rodríguez-Pardo D; Del Toro MD; Fernández-Sampedro M; Dapunt U; Huotari K; Davis JS; Palomino J; Neut D; Clark BM; Gottlieb T; Trebše R; Soriano A; Bahamonde A; Guío L; Rico A; Salles MJC; Pais MJG; Benito N; Riera M; Gómez L; Aboltins CA; Esteban J; Horcajada JP; O'Connell K; Ferrari M; Skaliczki G; Juan RS; Cobo J; Sánchez-Somolinos M; Ramos A; Giannitsioti E; Jover-Sáenz A; Baraia-Etxaburu JM; Barbero JM; Choong PFM; Asseray N; Ansart S; Moal GL; Zimmerli W; Ariza J;
    Clin Infect Dis; 2017 Jun; 64(12):1742-1752. PubMed ID: 28369296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France.
    Tonnelier M; Bouras A; Joseph C; Samad YE; Brunschweiler B; Schmit JL; Mabille C; Lanoix JP
    BMC Infect Dis; 2021 Feb; 21(1):174. PubMed ID: 33579208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure.
    Bouaziz A; Uçkay I; Lustig S; Boibieux A; Lew D; Hoffmeyer P; Neyret P; Chidiac C; Ferry T
    Med Mal Infect; 2018 May; 48(3):207-211. PubMed ID: 29122410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections.
    Kusejko K; Auñón Á; Jost B; Natividad B; Strahm C; Thurnheer C; Pablo-Marcos D; Slama D; Scanferla G; Uckay I; Waldmann I; Esteban J; Lora-Tamayo J; Clauss M; Fernandez-Sampedro M; Wouthuyzen-Bakker M; Ferrari MC; Gassmann N; Sendi P; Jent P; Morand PC; Vijayvargiya P; Trebše R; Patel R; Kouyos RD; Corvec S; Kramer TS; Stadelmann VA; Achermann Y
    Clin Infect Dis; 2021 Jun; 72(12):e1064-e1073. PubMed ID: 33300545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Debridement, antibiotics and implant retention for periprosthetic joint infections: A systematic review and meta-analysis of treatment outcomes.
    Kunutsor SK; Beswick AD; Whitehouse MR; Wylde V; Blom AW
    J Infect; 2018 Dec; 77(6):479-488. PubMed ID: 30205122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single vs 2-Stage Revision for the Treatment of Periprosthetic Joint Infection.
    Kildow BJ; Della-Valle CJ; Springer BD
    J Arthroplasty; 2020 Mar; 35(3S):S24-S30. PubMed ID: 32046827
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Albano M; Karau MJ; Greenwood-Quaintance KE; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failed Debridement and Implant Retention Does Not Compromise the Success of Subsequent Staged Revision in Infected Total Knee Arthroplasty.
    Kim K; Zhu M; Cavadino A; Munro JT; Young SW
    J Arthroplasty; 2019 Jun; 34(6):1214-1220.e1. PubMed ID: 30826164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
    Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
    Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofilm formation is associated with poor outcome in prosthetic joint infections caused by
    Hagstrand Aldman M; Thompson O; Påhlman LI
    Infect Dis (Lond); 2023 May; 55(5):328-332. PubMed ID: 36799228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-Year Results Following One-Stage Septic Hip Exchange in the Management of Periprosthetic Joint Infection.
    Zahar A; Klaber I; Gerken AM; Gehrke T; Gebauer M; Lausmann C; Citak M
    J Arthroplasty; 2019 Jun; 34(6):1221-1226. PubMed ID: 30857953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage procedure for chronic periprosthetic knee infection: the application of DAIR results in better remission rates and infection-free survivorship when used with topical degradable calcium-based antibiotics.
    Gramlich Y; Johnson T; Kemmerer M; Walter G; Hoffmann R; Klug A
    Knee Surg Sports Traumatol Arthrosc; 2020 Sep; 28(9):2823-2834. PubMed ID: 31321457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin Povidone-Iodine Protocol Improves Survivorship of Periprosthetic Joint Infection Treated With Irrigation and Debridement.
    Riesgo AM; Park BK; Herrero CP; Yu S; Schwarzkopf R; Iorio R
    J Arthroplasty; 2018 Mar; 33(3):847-850. PubMed ID: 29174761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatments for biofilm-associated periprosthetic joint infection and new potential strategies.
    Visperas A; Santana D; Klika AK; Higuera-Rueda CA; Piuzzi NS
    J Orthop Res; 2022 Jul; 40(7):1477-1491. PubMed ID: 35437846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of reinfection after prosthesis removal and antibiotic bone cement spacer implantation for the treatment of periprosthetic joint infection.
    Wang Q; Huang J; Chen X; Jin Y
    BMC Infect Dis; 2022 Dec; 22(1):905. PubMed ID: 36471324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-Resistant Organisms in the Setting of Periprosthetic Joint Infection-Diagnosis, Prevention, and Treatment.
    Siljander MP; Sobh AH; Baker KC; Baker EA; Kaplan LM
    J Arthroplasty; 2018 Jan; 33(1):185-194. PubMed ID: 28869114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.